InvestorsHub Logo
Followers 21
Posts 980
Boards Moderated 0
Alias Born 03/20/2019

Re: None

Wednesday, 10/02/2019 6:44:15 PM

Wednesday, October 02, 2019 6:44:15 PM

Post# of 425930
Although dated (from 2009) interesting quote from Dr. Kenneth Burman (chair of the AdCom) on Crestor:

Agency staff asked the advisory panel to weigh higher numbers of diabetes cases, gastrointestinal-related deaths and reports of a “confusional state” in patients who took Crestor instead of a placebo. Panelists generally agreed it was unlikely the deaths and confusion were related to Crestor.

On diabetes, panelists felt the Jupiter findings “probably represent an authentic increase” that may be common to all statins and urged further study, said panel chairman Dr. Kenneth Burman, chief of the endodrine section at Washington Hospital Center.

https://uk.reuters.com/article/astrazeneca-crestor/update-2-us-panel-backs-wider-use-of-astrazenecas-crestor-idUKN1521901920091215
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News